Botanix Pharmaceuticals Ltd. | |
Stock Exchange | Australian Stock Exchange |
EPS |
AUD0.02 |
Market Cap |
AUD170.29 M |
Shares Outstanding |
774.03 M |
Public Float |
526.11 M |
Address |
50 Angove Street North Perth Western Australia (WA) 6006 Australia |
Employees | - |
Website | http://www.botanixpharma.com |
Updated | 07/08/2019 |
Botanix Pharmaceuticals Ltd. engages in the development of next generation therapeutics for the treatment of skin diseases. It focuses on the treatment of patients battling with acne, psoriasis, and atoptic dermatitis. The company also develops pharmaceutical ingredient known as cannabidol, which seeks to treat epilepsy, pain, arthritis, and schizophrenia. |